Support hub to bring proven addiction treatments and overdose prevention to affected communities
HD2A RASC-SUD Implementation Support Core
This effort helps communities put proven treatments and overdose-prevention services for opioid and other substance use problems into local clinics and programs for people who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11180205 on NIH RePORTER |
What this research studies
The core team works with local clinics, health systems, and community partners to select evidence-based addiction medications and behavioral therapies that fit local needs. They provide training, technical assistance, and tools to help staff deliver these treatments and to track how well they reach people. The team uses implementation science methods to solve practical barriers, monitor outcomes, and help services keep running after initial support. If your community is hard hit by overdoses, this hub aims to make it easier to get proven care where you live.
Who could benefit from this research
Good fit: People with opioid or other substance use disorders who live in communities or receive care at clinics partnered with the implementation support network are the most likely candidates to benefit or participate.
Not a fit: People who live outside the networked communities, who cannot access participating clinics, or whose needs fall outside the supported interventions may not see direct benefit.
Why it matters
Potential benefit: If successful, this effort could increase access to effective addiction treatments and reduce overdose risk in communities that need them.
How similar studies have performed: Medications for opioid use disorder and evidence-based behavioral therapies have improved outcomes in many trials, and prior implementation projects have expanded access regionally, though wide-scale adoption remains challenging.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Becker, Sara — Stanford University
- Study coordinator: Becker, Sara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.